Prostamax
What is it?
A short peptide containing four amino acids, listed in the 2013 bioregulator catalogue in connection with prostate function. This is a research target, not an established treatment benefit.
Identity / background source ↗
Research context
Listed in the 2013 short-peptide review under the authors’ proposed prostate target. This historical label is not an established indication. Underlying studies need individual review.
- Working classification
- Short peptide research
- Research collection
- Peptide bioregulation · editorial grouping
- Institutional provenance
- Not established for this compound record
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —Not established by the catalogue
- Study methods
- —Mechanistic review / source table
- Independent replication
- —Not assessed
- Source access
- —Author-hosted English PDF
- Safety evidence
- —Not assessed
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Linked sources
Explore the research map and unresolved leads ↗
Mechanism of Biological Activity of Short Peptides: Cell Penetration and Epigenetic Regulation of Gene Expression
V. Kh. Khavinson, A. Yu. Solovyev, S. I. Tarnovskaya, N. S. Linkova · Biology Bulletin Reviews 3(6):451–455
Mechanistic review with a table of 15 short peptides on page 453. Tissue labels in the research map are the authors’ proposed targets, not established clinical indications.
- Population / setting
- Review of earlier research
- What was checked
- Author-hosted English PDF and its peptide table checked. Each cited experiment remains a separate appraisal task.
Limitations & review scope
- Source-linked does not mean a completed risk-of-bias review.
- A review is not an independent clinical replication; proposed mechanisms do not establish efficacy or safety.
Source checked 2026-09-27. This is a source-linked record, not a completed evidence review.